FDA Adverse Event
Malfunction
Summary report: N
INRATIO2
MDR report key: 1781389
·
Received July 30, 2010
Report
- Report Number
- 2027969-2010-01096
- Event Type
- Malfunction
- Date Received
- July 30, 2010
- Date of Event
- July 14, 2010
- Report Date
- July 30, 2010
- Manufacturer
- BIOSITE INCORPORATED
- Product Code
- GJS
- PMA / PMN Number
- K072727
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
Additional Manufacturer Narrative · 1
INVESTIGATION PENDING.
Description of Event or Problem · 1
PT SELF TESTER REPORTED DISCREPANT RESULTS: (B)(6) 2010, INRATIO: 1.3; (B)(6) 2010, INRATIO: 1.6, LAB: 2.5. PT'S THERAPEUTIC RANGE IS 2.0-3.0.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INRATIO2 | PROTHROMBIN TIME TEST | GJS | BIOSITE INCORPORATED | 100071 | 234130 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other | AN ACE INHIBITOR| MAINTANENCE PROTOCOL OF BACTRIM (BECAUSE PATIENT| FLOMAX| 80MG PER DAY OF AN UNK DIURETIC| LASIX| METHOTREXATE| IS IMMUNOCOMPROMISED)| A STATIN (FOR ELEVATED CHOLESTEROL)| INSULIN |